Clinical Trial

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Study acronym: XandTX
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The primary objective of this clinical trial is to evaluate whether primary total pancreatectomy with simultaneous islet autotransplantation compared with pancreatic head resection (alone) can reduce perioperative morbidity and time to initiation of adjuvant therapy in patients with a high-risk constellation for pancreatic fistulas.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2023-04-24; most recent amendment 2026-01-28.
Status change: Not Yet Recruiting → Recruiting 2025-01-02
Trial Details
NCT Number NCT05843877
Lead Sponsor Technische Universität Dresden
Collaborators: German Cancer Research Center
Conditions Periampullary Cancer, Postoperative Pancreatic Fistula
Enrollment 32 participants
Start Date 2025-01-28
Primary Completion 2028-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-30